AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27476829 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM customized zirconia abutment
Number of subjects: 50
Study 27476829 — intervention group
Group type: COMPARATOR
Intervention: Stock zirconia abutment
Number of subjects: 50
Study 25950595 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment
Number of subjects: 300
Study 24738837 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing combined with a self-management intervention
Number of subjects: 0
Study 22624531 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethylstarch 130/0.4 (HES)
Number of subjects: 196
Study 22624531 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (NaCl)
Number of subjects: 196
Study 19757261 — intervention group
Group type: EXPERIMENTAL
Intervention: PregVit (n = 106)
Number of subjects: 202
Study 19757261 — intervention group
Group type: EXPERIMENTAL
Intervention: Orifer F (n = 96)
Number of subjects: 202
Study 19757261 — intervention group
Group type: EXPERIMENTAL
Intervention: PregVit and Orifer F
Number of subjects: 202
Study 17267099 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic diagnostic (PDD)
Number of subjects: 301
Study 17267099 — intervention group
Group type: COMPARATOR
Intervention: White light (WL) cystoscopy
Number of subjects: 301
Study 15106023 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipitomental radiographs from general practice
Number of subjects: 247
Study 15106023 — intervention group
Group type: COMPARATOR
Intervention: Occipitomental radiographs from a certified laboratory
Number of subjects: 247
Study 11499848 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac prescriptions
Number of subjects: 0
Study 11499848 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple propensity score adjustment
Number of subjects: 0
Study 9272412 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole for 4 days
Number of subjects: 10
Study 9272412 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 days
Number of subjects: 10
Study 9272412 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole
Number of subjects: 10
Study 7878629 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg recombinant tissue plasminogen activator (t‐PA)
Number of subjects: 50
Study 7878629 — intervention group
Group type: COMPARATOR
Intervention: 10,000 units of urokinase (UK)
Number of subjects: 50
Study 3071175 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative continuous nifedipine maintenance medication (10-20 mg p.o.)
Number of subjects: 21
Study 3071175 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine morning dose
Number of subjects: 21
Study 3071175 — intervention group
Group type: COMPARATOR
Intervention: Control group (last nifedipine medication evening before surgery)
Number of subjects: 21
Study 29632081 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH‐HF intervention plus usual care
Number of subjects: 50
Study 29632081 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 50
Study 29632081 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH‐HF intervention
Number of subjects: 50
Study 28414485 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure therapy with incentives (PE + I; max $480)
Number of subjects: 58
Study 28414485 — intervention group
Group type: COMPARATOR
Intervention: Prolonged Exposure therapy (PE)
Number of subjects: 58
Study 25682177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear cataract increase of 1.0 unit or more compared with less than 1.0‐unit change at 2 years
Number of subjects: 3466
Study 25682177 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical cataract increase of 5% or more in lens opacity in the central 5 mm of the lens compared with less than 5% increase at 2 years
Number of subjects: 3466
Study 25682177 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior subcapsular cataract increase of 5% or more versus less than 5% in the central 5 mm of the lens
Number of subjects: 3466
Study 25682177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear cataract changes at 2 years
Number of subjects: 3466
Study 25682177 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical cataract changes at 2 years
Number of subjects: 3466
Study 25682177 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior subcapsular cataract changes at 2 years
Number of subjects: 3466
Study 23046014 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate (MAL) PDT with red light (22 J/cm²)
Number of subjects: 20
Study 23046014 — intervention group
Group type: COMPARATOR
Intervention: Methyl aminolevulinate (MAL) PDT with intense pulsed light (IPL) (8-10 J/cm²)
Number of subjects: 20
Study 23046014 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate (MAL) PDT with red light
Number of subjects: 20
Study 23046014 — intervention group
Group type: COMPARATOR
Intervention: Methyl aminolevulinate (MAL) PDT with IPL
Number of subjects: 20
Study 20628391 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan/5FU
Number of subjects: 149
Study 19064592 — intervention group
Group type: EXPERIMENTAL
Intervention: iomeprol-400
Number of subjects: 183
Study 19064592 — intervention group
Group type: COMPARATOR
Intervention: iodixanol-320
Number of subjects: 183
Study 16869923 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised patients trained in motivational interviewing for smoking cessation (n=47)
Number of subjects: 93
Study 16869923 — intervention group
Group type: COMPARATOR
Intervention: Student role-plays (n=46)
Number of subjects: 93
Study 14677790 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical aspirin paste
Number of subjects: 56
Study 14677790 — intervention group
Group type: COMPARATOR
Intervention: Ice pack
Number of subjects: 56
Study 10971310 — intervention group
Group type: EXPERIMENTAL
Intervention: Policosanol 5 mg day(-1)
Number of subjects: 69
Study 10971310 — intervention group
Group type: EXPERIMENTAL
Intervention: Policosanol 10 mg day(-1)
Number of subjects: 69
Study 10971310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 9214175 — intervention group
Group type: EXPERIMENTAL
Intervention: Brügger technique (lifting with bent legs and stretched back)
Number of subjects: 30
Study 9214175 — intervention group
Group type: COMPARATOR
Intervention: Lifting with stretched legs and bent back
Number of subjects: 30
Study 8408148 — intervention group
Group type: EXPERIMENTAL
Intervention: Open carpal tunnel release
Number of subjects: 145
Study 8408148 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release
Number of subjects: 145
Study 3489270 — intervention group
Group type: EXPERIMENTAL
Intervention: bepridil (2 mg/kg) administered by intravenous infusion over 30 min
Number of subjects: 10
Study 3489270 — intervention group
Group type: COMPARATOR
Intervention: placebo (5% glucose solution)
Number of subjects: 10
Study 3489270 — intervention group
Group type: EXPERIMENTAL
Intervention: bepridil (2 mg/kg)
Number of subjects: 10
Study 31581523 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol-enhanced arginine silicate oral supplement
Number of subjects: 60
Study 31581523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 26279065 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 g day-1 omega-3 polyunsaturated fatty acids (PUFAs) plus cognitive-behavioural case management (CBCM)
Number of subjects: 0
Study 26279065 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus cognitive-behavioural case management (CBCM)
Number of subjects: 0
Study 25257941 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% 5-fluorouracil with 10% salicylic acid (5-FU/SA)
Number of subjects: 66
Study 25257941 — intervention group
Group type: COMPARATOR
Intervention: Cryosurgery
Number of subjects: 66
Study 23249829 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy (ACE inhibitor ramipril + ARB telmisartan)
Number of subjects: 9628
Study 23249829 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (either ramipril or telmisartan)
Number of subjects: 9628
Study 23249829 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy
Number of subjects: 9628
Study 23249829 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy vs. monotherapy
Number of subjects: 9628
Study 23249829 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 9628
Study 21697170 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800
Study 21697170 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) with TAXUS Express stents
Number of subjects: 1800
Study 21697170 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800
Study 21697170 — intervention group
Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study 18309160 — intervention group
Group type: EXPERIMENTAL
Intervention: ECP (external counterpulsation)
Number of subjects: 50
Study 17000359 — intervention group
Group type: EXPERIMENTAL
Intervention: MCE-derived index of myocardial blood flow (A x beta)
Number of subjects: 30
Study 17000359 — intervention group
Group type: EXPERIMENTAL
Intervention: MCE-derived myocardial blood volume fraction (MBVF)
Number of subjects: 30
Study 17000359 — intervention group
Group type: COMPARATOR
Intervention: Contrast-enhanced magnetic resonance imaging (CE-MRI)
Number of subjects: 30
Study 14514768 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.0 microg/kg i.v. glycopyrrolate
Number of subjects: 36
Study 14514768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10966249 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO group (received iv iron and epoetin alfa 300 IU/kg subcutaneously on days 1, 3, 5, 7, and 9)
Number of subjects: 36
Study 10966249 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron group (received 20 mg of iron saccharate intravenously daily for 14 days)
Number of subjects: 36
Study 10966249 — intervention group
Group type: COMPARATOR
Intervention: Control group (received no additional therapy)
Number of subjects: 36
Study 8798250 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile for BMI in 10-14 year old girls
Number of subjects: 0
Study 8798250 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile for BMI in 15-19 year olds
Number of subjects: 0
Study 8798250 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI increase with age
Number of subjects: 0
Study 8798250 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean fasting insulin levels
Number of subjects: 0
Study 1451070 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent radiation therapy (RT) with vinblastine
Number of subjects: 29
Study 1451070 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 29
Study 6463915 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (400-600 micrograms)
Number of subjects: 12
Study 6463915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31210105 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 2 weeks for 12 weeks)
Number of subjects: 55
Study 29966780 — intervention group
Group type: EXPERIMENTAL
Intervention: WFNS grade I aSAH patients
Number of subjects: 132
Study 29966780 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (per increasing decade)
Number of subjects: 132
Study 29966780 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cerebral ischemia
Number of subjects: 132
Study 29966780 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumonia
Number of subjects: 132
Study 29966780 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningitis
Number of subjects: 132
Study 27185077 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 24
Study 27185077 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral simethicone)
Number of subjects: 24
Study 25316142 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamphenicol plus sodium hyaluronate 0.2% plus xylitol 5% (group B)
Number of subjects: 51
Study 25316142 — intervention group
Group type: COMPARATOR
Intervention: Thiamphenicol alone (group A)
Number of subjects: 51
Study 21688350 — intervention group
Group type: EXPERIMENTAL
Intervention: UC HAT
Number of subjects: 47
Study 21688350 — intervention group
Group type: COMPARATOR
Intervention: BAC
Number of subjects: 47
Study 20140409 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (50 units) injected into the plantar fascia
Number of subjects: 50
Study 20140409 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injected into the plantar fascia
Number of subjects: 50
Study 18059588 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre
Number of subjects: 9
Study 18059588 — intervention group
Group type: EXPERIMENTAL
Intervention: ImmPost
Number of subjects: 9
Study 18059588 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay
Number of subjects: 9
Study 18059588 — intervention group
Group type: COMPARATOR
Intervention: Pre and Delay
Number of subjects: 9
Study 15750366 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional stimuli (positive and negative emotions)
Number of subjects: 52
Study 15750366 — intervention group
Group type: COMPARATOR
Intervention: Neutral stimuli
Number of subjects: 52
Study 11875329 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (n = 56)
Number of subjects: 131
Study 11875329 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (n = 48)
Number of subjects: 131
Study 11875329 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 27)
Number of subjects: 131
Study 11459198 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone
Number of subjects: 9
Study 11459198 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 9
Study 10210990 — intervention group
Group type: EXPERIMENTAL
Intervention: High titre vaccine (10(3.9) and 10(4.0) pfu)
Number of subjects: 181
Study 10210990 — intervention group
Group type: EXPERIMENTAL
Intervention: Low titre vaccine (10(2.7) pfu)
Number of subjects: 181
Study 10210990 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination age of ≤ 14 months
Number of subjects: 181
Study 10210990 — intervention group
Group type: EXPERIMENTAL
Intervention: Household contact with varicella
Number of subjects: 181
Study 7941193 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic MRI with gadolinium‐diethylenetriamine pentaacetic acid (0.1 mmol/kg)
Number of subjects: 41
Study 7941193 — intervention group
Group type: COMPARATOR
Intervention: Follow-up controls
Number of subjects: 41
Study 3328684 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 0
Study 3328684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31464087 — intervention group
Group type: EXPERIMENTAL
Intervention: DSP-6952
Number of subjects: 88
Study 31464087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 29957095 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary goal of comfort
Number of subjects: 302
Study 29957095 — intervention group
Group type: COMPARATOR
Intervention: Other goals
Number of subjects: 302
Study 28594946 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring with biomass
Number of subjects: 120
Study 26214111 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused education and medication management intervention
Number of subjects: 101
Study 26214111 — intervention group
Group type: COMPARATOR
Intervention: Usual ED care
Number of subjects: 101
Study 24026258 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 792
Study 24026258 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily
Number of subjects: 792
Study 24026258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792
Study 20850731 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.30‐mg esterified estrogens and 0.30‐mg methyltestosterone combination
Number of subjects: 0
Study 20850731 — intervention group
Group type: EXPERIMENTAL
Intervention: Esterified estrogens and methyltestosterone alone or in combination
Number of subjects: 0
Study 19140846 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis (CAPD) in diabetic patients
Number of subjects: 17
Study 19140846 — intervention group
Group type: COMPARATOR
Intervention: Continuous ambulatory peritoneal dialysis (CAPD) in non-diabetic patients
Number of subjects: 17
Study 16638478 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 60
Study 16638478 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no hand massage)
Number of subjects: 60
Study 14669930 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate + alpha-lipoic acid + sucrose
Number of subjects: 16
Study 14669930 — intervention group
Group type: COMPARATOR
Intervention: Creatine monohydrate + sucrose
Number of subjects: 16
Study 14669930 — intervention group
Group type: COMPARATOR
Intervention: Creatine monohydrate alone
Number of subjects: 16
Study 10768801 — intervention group
Group type: EXPERIMENTAL
Intervention: Gimme 5 intervention (school-based media campaign, classroom workshops, school meal modification, parental involvement)
Number of subjects: 2213
Study 10768801 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2213
Study 8644543 — intervention group
Group type: EXPERIMENTAL
Intervention: Encircling buckling procedure (Group 2)
Number of subjects: 88
Study 8644543 — intervention group
Group type: EXPERIMENTAL
Intervention: Encircling with vitrectomy (Group 3)
Number of subjects: 88
Study 8644543 — intervention group
Group type: EXPERIMENTAL
Intervention: Encircling with local buckling (Group 4)
Number of subjects: 88
Study 8644543 — intervention group
Group type: COMPARATOR
Intervention: Local buckling (Group 1)
Number of subjects: 88
Study 8644543 — intervention group
Group type: EXPERIMENTAL
Intervention: All encircling procedures (Groups 2, 3, and 4)
Number of subjects: 88
Study 1635737 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytobrush/spatula
Number of subjects: 0
Study 1635737 — intervention group
Group type: COMPARATOR
Intervention: Cotton swab/spatula
Number of subjects: 0
Study 31757266 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day training in trauma inquiry plus a 1.5-hour refresher session 3 months later.
Number of subjects: 5204
Study 31757266 — intervention group
Group type: COMPARATOR
Intervention: No training (control group).
Number of subjects: 5204
Study 29775988 — intervention group
Group type: EXPERIMENTAL
Intervention: RT twice a week (G2X)
Number of subjects: 57
Study 29775988 — intervention group
Group type: EXPERIMENTAL
Intervention: RT three times a week (G3X)
Number of subjects: 57
Study 29775988 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control group (CG)
Number of subjects: 57
Study 26738606 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant TAC chemotherapy with zoledronic acid
Number of subjects: 216
Study 26738606 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant TAC chemotherapy without zoledronic acid
Number of subjects: 216
Study 26738606 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant T allele of 3129G > T in IGF1R (rs2016347)
Number of subjects: 216
Study 25028067 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash administered for 1 min before dental manipulation
Number of subjects: 101
Study 25028067 — intervention group
Group type: COMPARATOR
Intervention: Sterile water mouthrinse (control group)
Number of subjects: 101
Study 23057665 — intervention group
Group type: COMPARATOR
Intervention: Iron‐folate (FeFol = standard care)
Number of subjects: 0
Study 23057665 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN)
Number of subjects: 0
Study 23057665 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein‐energy (PE)
Number of subjects: 0
Study 23057665 — intervention group
Group type: EXPERIMENTAL
Intervention: PE + MMN
Number of subjects: 0
Study 23057665 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid‐based nutritional supplement with or without additional MMN
Number of subjects: 0
Study 20591543 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV16 L1 VLP vaccine
Number of subjects: 0
Study 17954806 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis case manager intervention
Number of subjects: 220
Study 17954806 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 220
Study 16282228 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief counseling session using empowerment techniques, motivational interviewing, identification of stressors and individual coping strategies, and educational materials
Number of subjects: 62
Study 16282228 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling intervention)
Number of subjects: 62
Study 16282228 — intervention group
Group type: COMPARATOR
Intervention: Self-reporting of tobacco use
Number of subjects: 62
Study 16282228 — intervention group
Group type: COMPARATOR
Intervention: Cotinine analysis
Number of subjects: 62
Study 12147200 — intervention group
Group type: EXPERIMENTAL
Intervention: Huangqi Jianzhong Tang
Number of subjects: 12
Study 12147200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10778587 — intervention group
Group type: EXPERIMENTAL
Intervention: Hartone 2 caps twice daily for 6 weeks and 1 cap twice daily for the next 6 weeks
Number of subjects: 10
Study 10778587 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide mononitrate (ISMN) 20 mg twice daily
Number of subjects: 10
Study 7874911 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercarbia stage (increased PaCO2 to > 55 torr)
Number of subjects: 15
Study 7874911 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate administration (4-mEq/kg iv dose)
Number of subjects: 15
Study 2191636 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose charcoal therapy (25 g of activated charcoal ingested at 4, 6, 8, and 10 hours after drug ingestion)
Number of subjects: 10
Study 2191636 — intervention group
Group type: COMPARATOR
Intervention: Control (no charcoal therapy)
Number of subjects: 10
Study 396084 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 9
Study 396084 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 9
Study 31138321 — intervention group
Group type: EXPERIMENTAL
Intervention: Single purse-string anastomosis
Number of subjects: 500